Smarter Decisions,
Better Care

UpToDate synthesizes the most recent medical information into evidence-based practical recommendations clinicians trust to make the right point-of-care decisions.

  • Rigorous editorial process: Evidence-based treatment recommendations
  • World-Renowned physician authors: over 5,100 physician authors and editors around the globe
  • Innovative technology: integrates into the workflow; access from EMRs

Choose from the list below to learn more about subscriptions for a:


Subscribers log in here


Central nervous system infections due to dematiaceous fungi (cerebral phaeohyphomycosis)

INTRODUCTION

Dematiaceous fungi have melanin-like pigments in the cell walls and can cause a variety of infections in humans known as phaeohyphomycosis (phaeo is Greek for "dark"). The most severe of the phaeohyphomycoses are infections of the central nervous system (CNS). The nomenclature of these infections is confusing, and there are scant data on appropriate management. The mycology, clinical features, and treatment of cerebral phaeohyphomycosis will be reviewed here.

MYCOLOGY

The common factor among the dematiaceous fungi is the presence of melanin pigments in the cell walls and spores. These pigments cause the hyphae to appear golden brown when examined under the microscope, and this can sometimes suggest the diagnosis when examining clinical histopathology specimens. The fungal nomenclature of the agents of cerebral phaeohyphomycosis has undergone much change, and this has resulted in confusion about the identities of the causative fungi. The most common causes of cerebral phaeohyphomycosis, for example, are Cladosporium trichoides [1,2], Xylohypha bantiana [3-7], Cladosporium bantianum [8], and Cladophialophora bantiana [9]. It is now generally accepted that all of these fungi should be collectively known as Cladophialophora bantiana. One can assume that all of the previous reports on infections due to these seemingly different fungi were caused by the same species.

Other causative fungi include Wangiella dermatitidis (also known as Exophiala dermatitidis) [10,11], Dactylaria gallopava (also known as Ochroconis gallopava) [12,13], Fonsecaea pedrosoi [14], Bipolaris spicifera (also known as Drechslera spicifera) [15,16], Rhinocladiella mackenziei (also known as Ramichloridium mackenziei and Ramichloridium obovoideum) [17,18], and Aureobasidium species [19]. Specimens are frequently not cultured; thus, species identifications are often not made [20]. In these cases, the diagnosis of phaeohyphomycosis depends upon demonstration of pigmented fungal structures by histopathology.

The dematiaceous fungi are found throughout the world in soil and decaying vegetation but appear to be especially common in tropical and subtropical regions. Most patients infected with Rhinocladiella mackenziei have been from Middle Eastern countries, including Saudi Arabia, Syria, or Kuwait [17,18,21,22], but cases have also been reported from India [23], Afghanistan [24], and Pakistan [25].

D. gallopava can causes encephalitis in turkeys, chickens, and other birds, but exposure to birds has not been linked to human disease [26-28].

       

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Sep 2014. | This topic last updated: Aug 6, 2013.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2014 UpToDate, Inc.
References
Top
  1. Aldape KD, Fox HS, Roberts JP, et al. Cladosporium trichoides cerebral phaeohyphomycosis in a liver transplant recipient. Report of a case. Am J Clin Pathol 1991; 95:499.
  2. Banerjee U, Mohapatra AK, Sarkar C, Chaudhery R. Cladosporiosis (cerebral phaeohyphomycosis) of brain--a case report. Mycopathologia 1989; 105:163.
  3. Buxi TB, Prakash K, Vohra R, Bhatia D. Imaging in phaeohyphomycosis of the brain: case report. Neuroradiology 1996; 38:139.
  4. Lirng JF, Tien RD, Osumi AK, et al. Cerebral phaeohyphomycosis complicated with brain abscess: a case report. Zhonghua Yi Xue Za Zhi (Taipei) 1995; 55:491.
  5. Mukherji SK, Castillo M. Cerebral phaeohyphomycosis caused by Xylohypha bantiana: MR findings. AJR Am J Roentgenol 1995; 164:1304.
  6. Palaoglu S, Sav A, Basak T, et al. Cerebral phaeohyphomycosis. Neurosurgery 1993; 33:894.
  7. Sekhon AS, Galbraith J, Mielke BW, et al. Cerebral phaeohyphomycosis caused by Xylohypha bantiana, with a review of the literature. Eur J Epidemiol 1992; 8:387.
  8. Hironaga M, Watanabe S. Cerebral phaeohyphomycosis caused by Cladosporium bantianum: a case in a female who had cutaneous alternariosis in her childhood. Sabouraudia 1980; 18:229.
  9. Walz R, Bianchin M, Chaves ML, et al. Cerebral phaeohyphomycosis caused by Cladophialophora bantiana in a Brazilian drug abuser. J Med Vet Mycol 1997; 35:427.
  10. Chang CL, Kim DS, Park DJ, et al. Acute cerebral phaeohyphomycosis due to Wangiella dermatitidis accompanied by cerebrospinal fluid eosinophilia. J Clin Microbiol 2000; 38:1965.
  11. Tintelnot K, de Hoog GS, Thomas E, et al. Cerebral phaeohyphomycosis caused by an Exophiala species. Mycoses 1991; 34:239.
  12. Vukmir RB, Kusne S, Linden P, et al. Successful therapy for cerebral phaeohyphomycosis due to Dactylaria gallopava in a liver transplant recipient. Clin Infect Dis 1994; 19:714.
  13. Sides EH 3rd, Benson JD, Padhye AA. Phaeohyphomycotic brain abscess due to Ochroconis gallopavum in a patient with malignant lymphoma of a large cell type. J Med Vet Mycol 1991; 29:317.
  14. al-Hedaithy SS, Jamjoom ZA, Saeed ES. Cerebral phaeohyphomycosis caused by Fonsecaea pedrosoi in Saudi Arabia. APMIS Suppl 1988; 3:94.
  15. Biggs PJ, Allen RL, Powers JM, Holley HP Jr. Phaeohyphomycosis complicating compound skull fracture. Surg Neurol 1986; 25:393.
  16. Yoshimori RN, Moore RA, Itabashi HH, Fujikawa DG. Phaeohyphomycosis of brain: granulomatous encephalitis caused by Drechslera spicifera. Am J Clin Pathol 1982; 77:363.
  17. Podnos YD, Anastasio P, De La Maza L, Kim RB. Cerebral phaeohyphomycosis caused by Ramichloridium obovoideum (Ramichloridium mackenziei): case report. Neurosurgery 1999; 45:372.
  18. Sutton DA, Slifkin M, Yakulis R, Rinaldi MG. U.S. case report of cerebral phaeohyphomycosis caused by Ramichloridium obovoideum (R. mackenziei): criteria for identification, therapy, and review of other known dematiaceous neurotropic taxa. J Clin Microbiol 1998; 36:708.
  19. Fletcher H, Williams NP, Nicholson A, et al. Systemic phaeohyphomycosis in pregnancy and the puerperium. West Indian Med J 2000; 49:79.
  20. Masini T, Riviera L, Cappricci E, Arienta C. Cerebral phaeohyphomycosis. Clin Neuropathol 1985; 4:246.
  21. Revankar SG, Sutton DA, Rinaldi MG. Primary central nervous system phaeohyphomycosis: a review of 101 cases. Clin Infect Dis 2004; 38:206.
  22. Kantarcioglu AS, de Hoog GS. Infections of the central nervous system by melanized fungi: a review of cases presented between 1999 and 2004. Mycoses 2004; 47:4.
  23. Badali H, Chander J, Bansal S, et al. First autochthonous case of Rhinocladiella mackenziei cerebral abscess outside the Middle East. J Clin Microbiol 2010; 48:646.
  24. Cristini A, Garcia-Hermoso D, Celard M, et al. Cerebral phaeohyphomycosis caused by Rhinocladiella mackenziei in a woman native to Afghanistan. J Clin Microbiol 2010; 48:3451.
  25. Jabeen K, Farooqi J, Zafar A, et al. Rhinocladiella mackenziei as an emerging cause of cerebral phaeohyphomycosis in Pakistan: a case series. Clin Infect Dis 2011; 52:213.
  26. Salkin IF, Dixon DM, Kemna ME, et al. Fatal encephalitis caused by Dactylaria constricta var. gallopava in a snowy owl chick (Nyctea scandiaca). J Clin Microbiol 1990; 28:2845.
  27. Blalock HG, Georg LK, Derieux WT. Encephalitis in turkey poults due to Dactylaria (Diplorhinotrichum) gallopava--a case report and its experimental reproduction. Avian Dis 1973; 17:197.
  28. Ranck FM Jr, Georg LK, Wallace DH. Dactylariosis--a newly recognized fungus disease of chickens. Avian Dis 1974; 18:4.
  29. Levin TP, Baty DE, Fekete T, et al. Cladophialophora bantiana brain abscess in a solid-organ transplant recipient: case report and review of the literature. J Clin Microbiol 2004; 42:4374.
  30. del Palacio-Hernanz A, Moore MK, Campbell CK, et al. Infection of the central nervous system by Rhinocladiella atrovirens in a patient with acquired immunodeficiency syndrome. J Med Vet Mycol 1989; 27:127.
  31. Centers for Disease Control and Prevention. Multi-state meningitis outbreak. http://www.cdc.gov/hai/outbreaks/meningitis.html (Accessed on January 15, 2013).
  32. Multistate outbreak of fungal infection associated with injection of methylprednisolone acetate solution from a single compounding pharmacy — United States, 2012. MMWR Morb Mortal Wkly Rep 2012; 61 (Early release):1.
  33. Center for Infectious Disease Research & Policy. Warnings, cases expand in fungal meningitis outbreak. http://www.cidrap.umn.edu/cidrap/content/other/news/oct1612fungusbr.html (Accessed on October 17, 2012).
  34. Roche M, Redmond RM, O'Neill S, Smyth E. A case of multiple cerebral abscesses due to infection with Cladophialophora bantiana. J Infect 2005; 51:e285.
  35. Delfino D, De Hoog S, Polonelli L, et al. Survival of a neglected case of brain abscess caused by Cladophialophora bantiana. Med Mycol 2006; 44:651.
  36. Al-Abdely HM, Najvar L, Bocanegra R, et al. SCH 56592, amphotericin B, or itraconazole therapy of experimental murine cerebral phaeohyphomycosis due to Ramichloridium obovoideum ("Ramichloridium mackenziei"). Antimicrob Agents Chemother 2000; 44:1159.
  37. Caligiorne RB, Resende MA, Melillo PH, et al. In vitro susceptibility of chromoblastomycosis and phaeohyphomycosis agents to antifungal drugs. Med Mycol 1999; 37:405.
  38. Espinel-Ingroff A, Boyle K, Sheehan DJ. In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature. Mycopathologia 2001; 150:101.
  39. Fothergill AW, Rinaldi MG, Sutton DA. Antifungal susceptibility testing of Exophiala spp.: a head-to-head comparison of amphotericin B, itraconazole, posaconazole and voriconazole. Med Mycol 2009; 47:41.
  40. Rivard RG, McCall S, Griffith ME, et al. Efficacy of caspofungin and posaconazole in a murine model of disseminated Exophiala infection. Med Mycol 2007; 45:685.
  41. Espinel-Ingroff A. In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature. Rev Iberoam Micol 2003; 20:121.
  42. Proia LA, Trenholme GM. Chronic refractory phaeohyphomycosis: successful treatment with posaconazole. Mycoses 2006; 49:519.
  43. Matsumoto T, Matsuda T, McGinnis MR, Ajello L. Clinical and mycological spectra of Wangiella dermatitidis infections. Mycoses 1993; 36:145.